<scp>CRISPR</scp> /Cas9‐mediated somatic correction of a novel coagulator factor <scp>IX</scp> gene mutation ameliorates hemophilia in mouse
2016 · EMBO Molecular Medicine · 166 citations
https://doi.org/10.15252/emmm.201506039
L
Liren Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
4.3K
Citations
34
h-index
59
i10-index
Liren Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: CRISPR and Genetic Engineering & Virus-based gene therapy research & RNA Interference and Gene Delivery. The author has an h-index of 34, co-authored 93 publications.
ORCID: 0009-0009-8737-2408Papers by this author
worksRe-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing
2022 · Nature Biotechnology · 150 citations
https://doi.org/10.1038/s41587-022-01532-7
Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos
2015 · Scientific Reports · 90 citations
https://doi.org/10.1038/srep17517
Injectable Biomimetic Hydrogel Guided Functional Bone Regeneration by Adapting Material Degradation to Tissue Healing
2023 · Advanced Functional Materials · 64 citations
https://doi.org/10.1002/adfm.202213047
Decellularization‐Based Modification Strategy for Bioactive Xenografts Promoting Tendon Repair
2023 · Advanced Healthcare Materials · 19 citations
https://doi.org/10.1002/adhm.202302660
CCN2 mediates fibroblast-macrophage interaction in knee arthrofibrosis based on single-cell RNA-seq analysis
2025 · Bone Research · 5 citations
https://doi.org/10.1038/s41413-025-00400-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat